Hepatocellular carcinoma, with portal thrombus after viral eradication, disappeared by 5-fluorouracil and interferon

被引：1

作者：

Tomofumi Miura ^{[1
]}

Nobuaki Suzuki ^{[1
]}

Junichiro Nakamura ^{[1
]}

Satoshi Yamada ^{[1
]}

Tsutomu Miura ^{[1
]}

Masahiko Yanagi ^{[1
]}

Hiroyuki Usuda ^{[2
]}

Iwao Emura ^{[3
]}

Toru Takahashi ^{[1
]}

机构：

[1] Division of Gastroenterology and Hepatology, Nagaoka Red Cross Hospital

[2] Division of Medical Technology, Nagaoka Red Cross Hospital

[3] Division of Pathology, Nagaoka Red Cross Hospital

来源：

World Journal of Hepatology | 2010年 / 2卷 / 11期

关键词：

Hepatocellular carcinoma; Portal vein tumor thrombus; Sustained virological response; 5-Fluorouracil intra-arterial infusion;

D O I：

暂无

中图分类号：

R735.7 [肝肿瘤];

学科分类号：

100214 ;

摘要：

Hepatocarcinogenesis after a sustained virological response (SVR) in type C chronic hepatitis and cirrhosis is an important issue in endemic areas; hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) therapy is especially very hard. We herein report a first case in which combination therapy with interferon-α and continuous intra-arterial infusion of 5-fluorouracil (designated as FAIT) provided a complete response in HCC with PVTT after SVR. Therefore, we think that FAIT is a good option to treat HCC with or without PVTT, even after SVR.

引用

页码：416 / 418

页数：3

共 50 条

[1] Hepatocellular carcinoma, with portal thrombus after viral eradication, disappeared by 5-fluorouracil and interferon
Miura, Tomofumi
Suzuki, Nobuaki
Nakamura, Junichiro
Yamada, Satoshi
Miura, Tsutomu
Yanagi, Masahiko
Usuda, Hiroyuki
Emura, Iwao
Takahashi, Toru
WORLD JOURNAL OF HEPATOLOGY, 2010, 2 (11) : 416 - 418
[2] 5-fluorouracil and alpha-interferon in hepatocellular carcinoma
Stuart, K
Tessitore, J
Huberman, M
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (02): : 136 - 139
[3] A pilot study of interferon alpha and 5-fluorouracil in hepatocellular carcinoma
Mughal, TI
Koriech, OM
ACTA ONCOLOGICA, 1996, 35 (02) : 248 - 248
[4] Pilot study of interferon alpha and 5-fluorouracil in hepatocellular carcinoma
Acta Oncol, 2 (248):
[5] Hepatic arterial infusion of 5-fluorouracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombus of the portal vein
Itamoto, T
Nakahara, H
Tashiro, H
Haruta, N
Asahara, T
Naito, A
Ito, K
JOURNAL OF SURGICAL ONCOLOGY, 2002, 80 (03) : 143 - 148
[6] Interferon-α and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules
Nagano, Hiroaki
Miyamoto, Atsushi
Wada, Hiroshi
Ota, Hideo
Marubashi, Shigeru
Takeda, Yutaka
Dono, Keizo
Umeshita, Koji
Sakon, Masato
Monden, Morito
CANCER, 2007, 110 (11) : 2493 - 2501
[7] Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion
Obi, S
Yoshida, H
Toune, R
Unuma, T
Kanda, M
Sato, S
Tateishi, R
Teratani, T
Shiina, S
Omata, M
CANCER, 2006, 106 (09) : 1990 - 1997
[8] Effect of a new adjuvant systemic interferon alpha, 5-Fluorouracil and cisplatin on advanced hepatocellular carcinoma with portal invasion macroscopic
Imura, Satoru
Ikemoto, Tetsuya
Morine, Yuji
Fujii, Masahiko
Miyake, Hidenori
Tashiro, Seiki
Shimada, Mitsuo
HEPATO-GASTROENTEROLOGY, 2008, 55 (82-83) : 615 - 620
[9] Arterial infusion of 5-fluorouracil combined with subcutaneous injection of pegylated interferon alpha-2b in treating unresectable hepatocellular carcinoma with portal vein tumor thrombus
Wu, Jian
Huang, Wen-Jin
Wang, Huan-Yu
Wang, Ya-Feng
Peng, Bao-Gang
Zhou, Qi
MEDICAL ONCOLOGY, 2015, 32 (03)
[10] Arterial infusion of 5-fluorouracil combined with subcutaneous injection of pegylated interferon alpha-2b in treating unresectable hepatocellular carcinoma with portal vein tumor thrombus
Jian Wu
Wen-Jin Huang
Huan-Yu Wang
Ya-Feng Wang
Bao-Gang Peng
Qi Zhou
Medical Oncology, 2015, 32

← 1 2 3 4 5 →